LACOG 0319

OC Oncoclínicas NOB

Head and neck

Quality of Life Assessment Study in Patients with Metastatic Head and Neck Neoplasia submitted to Immunotherapy in Brazil – LACOG 0319

Centro

OC Oncoclínicas NOB

Investigador principal

André Barcelar

Email

pesquisaclinicabahia@oncoclinicas.com

Telefone

(71) 98314-0522/71 e 4009-7085/7086/7087

Critérios de inclusão

Patients diagnosed with recurrent or metastatic epidermoid carcinoma of the head and neck region, whose disease has progressed up to 6 months from the beginning of the last cycle of systemic treatment with platinum, and who are using immunotherapy (nivolumab);

Patients with primary tumors of the pharynx (oro or hypopharynx), oral cavity and larynx;